A dedicated onconephrology service at Brigham and Women’s Hospital has improved kidney outcomes in patients treated for ...

GSK is acquiring an experimental medicine from a Cambridge biotech to shore up its drug pipeline and muscle into the ...

Just a day after dropping a $625m cancer asset, GSK has inked a deal worth a potential $2bn to acquire Boston Pharmaceuticals ...

GSK has agreed to pay $1.2 billion upfront to acquire rights to efimosfermin from Cambridge, Massachusetts-based Boston ...

Wall Street firms are trying to put private credit, equity and real estate into the hands of individual investors. Surging medical costs and regulatory changes hit UnitedHealth, but rivals such as ...